4.6 Article

Early Pregnancy Atherogenic Profile in a First Pregnancy and Hypertension Risk 2 to 7 Years After Delivery

Journal

Publisher

WILEY
DOI: 10.1161/JAHA.120.017216

Keywords

high blood pressure; hypertension; lipids; preeclampsia; pregnancy; pregnancy and postpartum

Funding

  1. Eunice Kennedy Shriver National Institute of Child Health and Human Development [U10-HL119991, U10-HL119989, U10--HL120034, U10-HL119990, U10-HL120006, U10-HL119992, U10-HL120019, U10-HL119993, U10-HL120018, U01HL145358]
  2. National Heart, Lung, and Blood Institute
  3. National Institutes of Health Office of Research on Women's Health [U10-HL-119991]
  4. Office of Behavioral and Social Sciences Research [U10-HL119991, U10-HL119992]
  5. National Center for Advancing Translational Sciences [UL-1-TR000124, UL-1-TR000153, UL-1-TR000439, UL-1-TR001108]
  6. Barbra Streisand Women's Cardiovascular Research and Education Program
  7. Erika J. Glazer Women's Heart Research Initiative

Ask authors/readers for more resources

In primiparous women, APO/GDM is associated with atherosclerotic characteristics and increased risk of hypertension later. Higher glucose, high-sensitivity C-reactive protein, and triglycerides levels are linked to hypertension, while increased physical activity is protective. Nonobese individuals with higher lipid, high-sensitivity C-reactive protein, and insulin levels have increased risk of APO/GDM and hypertension.
BACKGROUND: Cardiovascular risk in young adulthood is an important determinant of lifetime cardiovascular disease risk. Women with adverse pregnancy outcomes (APOs) have increased cardiovascular risk, but the relationship of other factors is unknown. METHODS AND RESULTS: Among 4471 primiparous women, we related first-trimester atherogenic markers to risk of APO (hypertensive disorders of pregnancy, preterm birth, small for gestational age), gestational diabetes mellitus (GDM) and hypertension (130/80 mm Hg or antihypertensive use) 2 to 7 years after delivery. Women with an APO/GDM (n=1102) had more atherogenic characteristics (obesity [34.2 versus 19.5%], higher blood pressure [systolic blood pressure 112.2 versus 108.4, diastolic blood pressure 69.2 versus 66.6 mm Hg], glucose [5.0 versus 4.8 mmol/ L], insulin [77.6 versus 60.1 pmol/L], triglycerides [1.4 versus 1.3 mmol/L], and high-sensitivity C-reactive protein [5.6 versus 4.0 nmol/L], and lower high-density lipoprotein cholesterol [1.8 versus 1.9 mmol/L]; P<0.05) than women without an APO/GDM. They were also more likely to develop hypertension after delivery (32.8% versus 18.1%, P<0.05). Accounting for confounders and factors routinely assessed antepartum, higher glucose (relative risk [RR] 1.03 [95% CI, 1.00-1.06] per 0.6 mmol/L), high-sensitivity C-reactive protein (RR, 1.06 [95% CI, 1.02-1.11] per 2-fold higher), and triglycerides (RR, 1.27 [95% CI, 1.14-1.41] per 2-fold higher) were associated with later hypertension. Higher physical activity was protective (RR, 0.93 [95% CI, 0.87-0.99] per 3 h/week). When evaluated as latent profiles, the nonobese group with higher lipids, high-sensitivity C-reactive protein, and insulin values (6.9% of the cohort) had increased risk of an APO/GDM and later hypertension. Among these factors, 7% to 15% of excess RR was related to APO/GDM. CONCLUSIONS: Individual and combined first-trimester atherogenic characteristics are associated with APO/GDM occurrence and hypertension 2 to 7 years later.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available